Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Raymond James Maintains Outperform on Compass Therapeutics, Raises Price Target to $8

Raymond James Maintains Outperform on Compass Therapeutics, Raises Price Target to $8

Raymond James analyst Dane Leone maintains Compass Therapeutics (NASDAQ:CMPX) with a Outperform and raises the price target from $5 to $8.

November 10, 2022

1 minute read

Raymond James analyst Dane Leone maintains Compass Therapeutics (NASDAQ:CMPX) with a Outperform and raises the price target from $5 to $8.

Analyzing AstraZeneca In Comparison To Competitors In Pharmaceuticals Industry

December 12, 12:00 PM

Amidst today’s fast-paced and highly competitive business environment, it is crucial for investors and industry enthusiasts to conduct…

December 20, 10:48 AM

United Parcel Service Inc (NYSE: UPS) shares are trading lower Wednesday in sympathy with FedEx Corp (NYSE: FDX), which reported

February 8, 8:57 AM

Stephens & Co. analyst Charles Nabhan maintains Jack Henry & Associates (NASDAQ:JKHY) with a Equal-Weight and maintains $185 price target.

August 7, 2:28 AM

Musk first touted the idea of a drive-in restaurant in LA in January 2018.